| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/10/1992 | EP0489181A1 Solid preparation |
| 06/10/1992 | EP0428582B1 Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances |
| 06/10/1992 | EP0310645B1 Compounds useful particularly for radiotherapy or imaging of cancer |
| 06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
| 06/09/1992 | US5120816 Reaction product of the mixture of long chain and medium chain polyoxyethylene glycol, chain extender, water and diisocyanate |
| 06/09/1992 | US5120762 Method for production of stabilized sodium ascorbate powder |
| 06/09/1992 | US5120731 Stabilization of perfluorocarbon emulsions, and perfluorinated heterocyclic compounds usable as emulsion-stabilizing additives |
| 06/09/1992 | US5120720 Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers |
| 06/09/1992 | US5120719 Conjugate of prostaglandin and polysaccharide |
| 06/09/1992 | US5120716 Percutaneous absorption promoting agent and dermatologic preparation containing the same |
| 06/09/1992 | US5120710 Oral lipid medicinal composition |
| 06/09/1992 | US5120546 Transdermal system |
| 06/09/1992 | US5120544 Mixing water, carboxymethyl cellulose powder, an emulsifier and a drug, heating, cooling, crosslinking with aluminum acetate, shaping and curing; for transdermal drug delivery |
| 06/09/1992 | US5120539 Diarrhea therapy for infants |
| 06/09/1992 | US5120537 Factor X or fragment thereof having little or no serine esterase activity, which is capable of binding with factor V in the blood of a mammal, and a carrier |
| 06/09/1992 | US5120525 Radiolabeled antibody cytotoxic therapy of cancer |
| 06/09/1992 | CA1302893C Hyaluronate-poly(ethylene oxide) mixtures |
| 06/08/1992 | WO1992010172A1 Solid dosage forms of almokalant and processes for manufacture thereof |
| 06/08/1992 | CA2097178A1 Solid dosage forms of almokalant and processes for manufacture thereof |
| 06/08/1992 | CA2097175A1 Method for the manufacture of a controlled release solid unit dosage form |
| 06/06/1992 | WO1992010173A1 Pharmaceutical compositions |
| 06/06/1992 | CA2097495A1 Pharmaceutical compositions |
| 06/03/1992 | EP0488583A2 Improved kit and method for administration of bacillus calmette-guerin |
| 06/03/1992 | EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 06/03/1992 | EP0488258A2 Propenamide derivatives, polymers, copolymers and use thereof |
| 06/03/1992 | EP0488181A1 Hard capsule preparation containing nifedipine |
| 06/03/1992 | EP0488139A1 Pharmaceutical composition comprising calcium polycarbophil |
| 06/03/1992 | EP0487973A1 Topical lotion containing Niclosamide |
| 06/03/1992 | EP0487768A1 Pharmaceutical composition with improved dissolution property |
| 06/03/1992 | EP0487729A1 Ketotifen preparation for external use |
| 06/03/1992 | EP0487648A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
| 06/03/1992 | EP0487632A1 Stabilized vaccine compositions |
| 06/03/1992 | EP0487615A1 Ferritin analogs. |
| 06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions |
| 06/03/1992 | EP0359746B1 Use of vinyl alcohol homopolymers and copolymers for tableting active materials |
| 06/03/1992 | EP0219539B1 Transdermal nitroglycerin delivery system |
| 06/02/1992 | US5118845 Penetration enhancer for transdermal delivery of systemic agents |
| 06/02/1992 | US5118808 Pharmaceutical preparations |
| 06/02/1992 | US5118698 Pharmaceutical preparations |
| 06/02/1992 | US5118692 Penetration enhances for transdermal delivery of systemic agents |
| 06/02/1992 | US5118676 Penetration enhancers for transdermal delivery of systemic agents |
| 06/02/1992 | US5118510 Niacin drink mix formulation |
| 06/02/1992 | US5118494 Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 06/02/1992 | CA1302324C Ex vivo effector cell activation for target cell killing |
| 06/02/1992 | CA1302279C Solid dispersion composition of fr-900506 substance |
| 06/02/1992 | CA1302278C Injection solutions of torasemide which are ready to use and processes for their preparation thereof |
| 06/02/1992 | CA1302269C Penetrating topical pharmaceutical compositions |
| 06/02/1992 | CA1302267C Oral therapeutic system having systemic action |
| 06/02/1992 | CA1302261C Buccal drug dosage form |
| 06/02/1992 | CA1302256C Topical drug release system |
| 05/31/1992 | WO1992009627A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor |
| 05/31/1992 | CA2074945A1 Tumor cell invasion-inhibiting peptides, peptide complexes and cancer metastasis inhibitors |
| 05/31/1992 | CA2056513A1 A controlled-release pharmaceutical preparation for intra-ocular implant |
| 05/30/1992 | WO1992009894A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 05/30/1992 | CA2095237A1 Methods for detection and quantitation of cell subsets within subpopulations of a mixed cell population |
| 05/30/1992 | CA2056032A1 Hard capsule preparation |
| 05/29/1992 | WO1992008790A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| 05/29/1992 | WO1992008685A1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds |
| 05/29/1992 | WO1992008494A2 Targeting radioactive immunoreagents |
| 05/29/1992 | WO1992008478A1 Method of enhancing long-term storage stability of hemoglobin products |
| 05/29/1992 | WO1992008447A1 Aerosol containing medicaments |
| 05/29/1992 | WO1992008439A1 Foamable washing composition based on selected insoluble silicones and an alkylpolyglycoside, and cosmetic and dermatological uses thereof |
| 05/29/1992 | WO1992005866A3 Efficient microcapsule preparation and method of use |
| 05/29/1992 | CA2096233A1 Formable washing composition based on selected insoluble silicones and an alkylpolyglycoside, and cosmetic and dermatological uses thereof |
| 05/29/1992 | CA2073511A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
| 05/29/1992 | CA2055715A1 Kit and method for administration of bacillus calmette-guerin |
| 05/28/1992 | WO1992009299A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/28/1992 | WO1992009286A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/28/1992 | CA2096962A1 Composition containing antihistamine h2 receptor antagonists and bioadhesive material |
| 05/28/1992 | CA2072983A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/27/1992 | WO1992009635A1 Methyl pyrrolidinone chitosan, production process and uses thereof |
| 05/27/1992 | WO1992009283A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
| 05/27/1992 | EP0487066A1 Disinfectant composition |
| 05/27/1992 | EP0486998A1 Slow-releasing composition of platinum-containing anticancer agent |
| 05/27/1992 | EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it |
| 05/27/1992 | EP0486854A1 Aqueous compositions containing calcitonin for the nasal administration |
| 05/27/1992 | EP0486688A1 New lysozyme-digestive chitin derivative |
| 05/27/1992 | EP0486529A1 Transdermal nitroglycerin patch with penetration enhancers |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |
| 05/27/1992 | EP0486499A1 Stable ascorbic acid compositions. |
| 05/27/1992 | EP0201601B1 Glass microspheres |
| 05/27/1992 | CN1061415A Complexes containing s(+) phenyl alkane acids and amino sugars |
| 05/27/1992 | CN1061340A Semduramicin premix |
| 05/27/1992 | CA2074517A1 Methyl pyrrolidinone chitosan, production process and uses thereof |
| 05/27/1992 | CA2074484A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
| 05/26/1992 | US5116949 Benzoyl urea compound-albumin complex |
| 05/26/1992 | US5116944 Conjugates having improved characteristics for in vivo administration |
| 05/26/1992 | US5116817 LHRH preparations for intranasal administration |
| 05/26/1992 | US5116753 Maintenance of pancreatic islets |
| 05/26/1992 | US5116621 Anti-inflammatory analgesic patch |
| 05/26/1992 | US5116613 Antibody-thrombolytic agent product and method of use |
| 05/21/1992 | WO1992008729A1 Antisense nucleic acid derivative |
| 05/21/1992 | CA2096658A1 Anti-sense nucleic acid derivative |
| 05/21/1992 | CA2055844A1 Slow-releasing composition of platinum-containing anticancer agent |
| 05/20/1992 | EP0486395A1 Aqueous gel based on retinoic acid and hydroxypropyl-beta-cycclodextrin |
| 05/20/1992 | EP0486353A1 Anhydrous composition containing lactulose |
| 05/20/1992 | EP0486315A2 Process for preparing neotrehalose and its uses |
| 05/20/1992 | EP0486046A2 S(+)-Phenyl-alkanoic acids and aminosugar containing complexes |
| 05/20/1992 | EP0485749A2 Chemical modification of antibodies for creating of immunoconjugates |
| 05/20/1992 | EP0485708A2 Stabilized PVC products and their production |